In a recent review article published in the journal Microsystems & Nanoengineering, researchers explored the advancements in microfluidic technologies for monitoring the electromechanical activity of ...
Preclinical research and development are the cornerstone of modern drug discovery. A variety of biological systems including in vitro, 3D cultures, and organoids are essential tools, with ultimately ...
This collection highlights recent publications in Nature Communications on microfluidic advances: both technical improvements and those with exciting biological applications. We showcase the areas ...
Researchers at the University of Toronto's Faculty of Applied Science & Engineering have designed a new microfluidic platform that allows for unprecedented control and manipulation of tumor shapes—a ...
Engineers have developed an automated microfluidic platform that dramatically accelerates the formulation of lipid nanoparticles, the delivery vehicles behind mRNA vaccines and gene therapies.
Making its latest foray into the microfluidics ring, Hopkinton, Mass.-based Caliper Life Sciences https://www.caliperls.com has introduced the new LabChip 3000 Drug Discovery System, a ...
Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...
Thousands of researchers worldwide have utilized microfluidics technology from Standard BioTools for genomics applications including genotyping, gene expression, and next-generation sequencing (NGS) ...
SAN FRANCISCO--(BUSINESS WIRE)--Miroculus, Inc., developer of revolutionary tools for personal lab automation, today announced its partnership with Element Biosciences, Inc., developer of the AVITI ...
AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results